SEC Form 4 · accession 0001293577-16-000002
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard D Katz
Officer — VP & Chief Financial Officer
Period of report
Jul 11, 2016
Accepted (ET)
Jul 13, 2016 · 9:27 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.30 | Jul 11, 2016 | A | 300,000 | A | — | Jul 10, 2026 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1This option was granted on July 11, 2016 and vests as to 25% of the shares underlying this option on July 11, 2017, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning July 11, 2017.